Purine derivatives as potent γ-secretase modulators
摘要:
The development of a novel series of purines as gamma-secretase modulators for potential use in the treatment of Alzheimer's disease is disclosed herein. Optimization of a previously disclosed pyrimidine series afforded a series of potent purine-based gamma-secretase modulators with 300- to 2000-fold in vitro selectivity over inhibition of Notch cleavage and that selectively reduces A beta 42 in an APP-YAC transgenic mouse model. (C) 2010 Elsevier Ltd. All rights reserved.
Regioselective N-alkylation of 1,3-azoles is a valuable transformation. Organomagnesium reagents were discovered to be competent bases to affect regioselective alkylation of various 1,3-azoles. Counterintuitively, substitution selectively occurred at the more sterically hindered nitrogen atom. Numerous examples are provided, on varying 1,3-azole scaffolds, with yields ranging from 25 to 95%.
Direct, Regioselective <i>N</i>-Alkylation of 1,3-Azoles
作者:Shuai Chen、Russell F. Graceffa、Alessandro A. Boezio
DOI:10.1021/acs.orglett.5b02994
日期:2016.1.4
Regioselective N-alkylation of 1,3-azoles is a valuable transformation. Organomagnesium reagents were discovered to be competent bases to affect regioselective alkylation of various 1,3-azoles. Counterintuitively, substitution selectively occurred at the more sterically hindered nitrogen atom. Numerous examples are provided, on varying 1,3-azole scaffolds, with yields ranging from 25 to 95%.
Purine derivatives as potent γ-secretase modulators
作者:Alexey Rivkin、Sean P. Ahearn、Stephanie M. Chichetti、Christopher L. Hamblett、Yudith Garcia、Michelle Martinez、Jed L. Hubbs、Michael H. Reutershan、Matthew H. Daniels、Phieng Siliphaivanh、Karin M. Otte、Chaomin Li、Andrew Rosenau、Laura M. Surdi、Joon Jung、Bethany L. Hughes、Jamie L. Crispino、George N. Nikov、Richard E. Middleton、Christopher M. Moxham、Alexander A. Szewczak、Sanjiv Shah、Lily Y. Moy、Candia M. Kenific、Flobert Tanga、Jonathan C. Cruz、Paula Andrade、Minilik H. Angagaw、Nirah H. Shomer、Thomas Miller、Benito Munoz、Mark S. Shearman
DOI:10.1016/j.bmcl.2010.02.008
日期:2010.4
The development of a novel series of purines as gamma-secretase modulators for potential use in the treatment of Alzheimer's disease is disclosed herein. Optimization of a previously disclosed pyrimidine series afforded a series of potent purine-based gamma-secretase modulators with 300- to 2000-fold in vitro selectivity over inhibition of Notch cleavage and that selectively reduces A beta 42 in an APP-YAC transgenic mouse model. (C) 2010 Elsevier Ltd. All rights reserved.